Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 July, 2017 20:19 IST
Alembic Pharma gets USFDA's tentative nod for Vilazodone HCl tablets
Source: IRIS | 19 Apr, 2017, 11.14AM
Comments  |  Post Comment

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vilazodone Hydrochloride Tablets, 10mg, 20mg and 40mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Viibryd Tablets, 10 mg, 20mg and 40mg, of Forest Labs LLC. Vilazodone Hydrochloride Tablets are indicated for the treatment of Major Depressive Disorder (MDD). Alembic is currently in litigation with Forest Labs LLC in District Court of Delaware and has stipulated to stay the case in view of the ongoing settlement discussions.

Vilazodone Hydrochloride Tablets have an estimated market size of USD 340 million for twelve months ending December 2016 according to IMS.

Alembic now has a total of 54 ANDA approvals (47 final approvals and 7 tentative approvals) from the USFDA.

Shares of the company gained Rs 12, or 1.97%, to trade at Rs 621.95. The total volume of shares traded was 7,783 at the BSE (11.05 a.m., Wednesday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Aurionpro's arm inks pact with HPE for powering Isla - 25-Jul-2017 13:21
Unichem gets ANDA approval for Losartan Potassium, Hydrochlorothiazide tablets - 25-Jul-2017 13:18
Zydus receives final approval from USFDA for Mesalamine Delayed-Release Tablets - 25-Jul-2017 13:14
Ambuja Cements quarterly net up 12% - 25-Jul-2017 10:23
Ratnamani Metals bags two new orders worth Rs 3.39 bn - 25-Jul-2017 10:14
Welspun Enterprises to expand infrastructure operations - 25-Jul-2017 10:09
Wipro partners HPE to offer IT Infra Solutions - 25-Jul-2017 10:03
Glenmark gets final approval from USFDA for Desonide Cream - 25-Jul-2017 09:50
Moody's affirms ratings of seven and downgrades ratings of two Indian public sector banks - 24-Jul-2017 16:28
Moody's affirms ratings of Axis Bank, ICICI Bank; revises outlooks to stable - 24-Jul-2017 16:22
Ashok Leyland bags order worth Rs 6.50 bn - 24-Jul-2017 15:51
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer